Analysis

Adocia Sa (ADOC) Stock Analysis

Adocia Sa investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to ADOC.

websiteADOC/analysis/ADOC

Adocia Sa

Adocia Sa investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to ADOC.

Stock profile

Ticker

ADOC

Asset type

Stock

Market cap

$93.9M

Sector

Health Technology

Industry

Pharmaceuticals: Major

Currency

EUR

Ticker listings

Adocia Sa may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • ADOC primary listing
  • 0QAI
  • A1JTC2
  • A89
  • ADOCY
  • ADOCP

Latest Adocia Sa news

Number of Shares and Voting Rights of ADOCIA as of May 31st, 2026

LYON, France, June 11, 2026--Regulatory News: Pursuant to the provisions of article L. 233-8 II of the French "Code de Commerce" and article 223-16 of the General Regulation of ...

ADOCIA Announces THDB0206 (BioChaperone® Lispro) Phase 3 Data in Type 2 Diabetes Presented at ADA 86th Scientific Sessions, Confirming th...

LYON, France, June 08, 2026--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of...

ADOCIA Reports First Quarter 2026 Financial Results and Provides a Business Update

LYON, France, May 12, 2026--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC, the "Company"), a clinical-stage biopharmaceutical company focused on the research and ...

ADOCIA Announces its Annual Shareholders’ Meeting to be Held on June 3rd, 2026 in Paris

LYON, France, May 11, 2026--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development of ...

ADOCIA Announces the Release of its Universal Registration Document for the Year 2025

LYON, France, April 29, 2026--Regulatory News: Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company focused on the research and development o...

Research sections

Valuation

Review valuation context for Adocia Sa.

Future growth

Review future growth context for Adocia Sa.

Past performance

Review past performance context for Adocia Sa.

Financial health

Review financial health context for Adocia Sa.

Dividend

Review dividend context for Adocia Sa.

Management

Review management context for Adocia Sa.

Ownership

Review ownership context for Adocia Sa.

Other information

Review other information context for Adocia Sa.

Community

Review community context for Adocia Sa.